CardioMech taps medtech vet Nehm for CEO | Personnel Moves, November 5, 2018

 CardioMech taps medtech veteran Nehm for CEO Swedish mitral valve repair company CardioMech said today that it named medical device industry veteran Richard Nehm as president & CEO effective immediately. Nehm’s resume includes stints at Boston Scientific (NYSE:BSX), Abbott (NYSE:ABT) acquisition Tendyne and ATS Medical (acquired by Medtronic (NYSE:MDT)). CardioMech also named Spinal Stabilization Technologies president & CEO Mark Novotny as chairman. “There are more than 400,000 patients around the world that suffer from a leaky mitral valve due to prolapse or flail that are at a high-risk for a cardiac surgery. We are pleased to welcome Rick and Mark to help us accelerate the development of our catheter-based technology that is designed to treat these patients with a transfemoral/transseptal access without the risks associated with open-heart surgery, cardiac arrest and the heart-lung bypass machine,” co-founder & chief medical officer Dr. Jacob Bergsland said in prepared remarks. “I am thrilled to join this extraordinary team and lead CardioMech down the path towards commercialization of this profound technology. Our objective is to significantly improve the standard of care for very sick patients suffering with mitral valve prolapse and flail,” Nehm added. “Transcatheter chordal repair is a hot segment with two exits in the last 11 months. The CardioMech device is highly differentiated, and we will build significant shareh...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Cantel Medical Corp. CardioMech Eos Imaging intersectent Medibio micronsolutions Personnel Moves Restoration Robotics Inc. Stereotaxis SurModics Inc. Vascular Insights Source Type: news